# Salivary Apelin, Chemerin, Ghrelin, and Lipocalin-2 Levels in Diabetic Patients With Periodontitis

> **NCT07703345** · — · RECRUITING · sponsor: **Necmettin Erbakan University** · enrollment: 88 (estimated)

## Conditions studied

- Periodontitis
- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DIAGNOSTIC_TEST:** Salivary Biomarker Analysis

## Key facts

- **NCT ID:** NCT07703345
- **Lead sponsor:** Necmettin Erbakan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703345, "Salivary Apelin, Chemerin, Ghrelin, and Lipocalin-2 Levels in Diabetic Patients With Periodontitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*